Lantern Pharma
LTRN
LTRN
22 hedge funds and large institutions have $19.7M invested in Lantern Pharma in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $25.5M → $19.7M (-$5.8M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.21M | |
| 2 | +$219K | |
| 3 | +$150K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$141K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$89.2K |
Top Sellers
| 1 | -$2.68M | |
| 2 | -$839K | |
| 3 | -$764K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$203K |
| 5 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$17K |